Skip to main content
HCSG
NASDAQ Industrial Applications And Services

HCSG Q3 EPS $0.36; Raises 2027 Revenue Growth Outlook to Low Double-Digits

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$21.41
Mkt Cap
$1.476B
52W Low
$16.27
52W High
$25.75
52W Position info
32% above low
Off High info
17% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

HCSG sits 32% above its 52-week low of $16.27.

Summary

HCSG reported Q3 revenue of $479.6 million and EPS of $0.36, then raised its 2027 revenue growth outlook to low double-digits, with Q4 guided to $535-$545 million as the NEXDINE acquisition begins contributing.


Key Events · Earnings and Guidance · HCSG

  • Q3 Results In Line

    Revenue of $479.6 million and diluted EPS of $0.36, with net income of $24.9 million; cost of services was 83.2% of revenue versus an 86% target.

  • 2027 Growth Outlook Raised

    Management lifted its 2027 revenue growth expectation from mid single-digits to low double-digits and guided Q4 2026 revenue to $535-$545 million.

  • NEXDINE Deal Closed October 6

    $93.5 million cash acquisition funded from cash on hand, expected to add over $150 million in annual revenue at margins comparable to HCSG's and be immediately accretive to earnings.

  • Genesis Bankruptcy Recovery

    Recorded an estimated $6.1 million recovery after the court-approved sale of Genesis on October 14, 2026; a higher potential recovery exists but cannot be reasonably estimated yet.


Analysis · HCSG · Industrial Applications And Services

The real news here is the forward guidance, not the quarter itself: revenue of $479.6 million and EPS of $0.36 landed roughly in line with the headline numbers already circulating, but management lifted its 2027 revenue growth target from mid single-digits to low double-digits and guided Q4 revenue to $535-$545 million. Driving that step-up is largely the NEXDINE acquisition, which closed October 6 for $93.5 million in cash and is expected to add over $150 million of annual revenue at comparable margins while being immediately accretive to earnings. The quarter also carried a $6.1 million estimated recovery tied to the Genesis bankruptcy sale approved October 14, with management flagging a potentially higher recovery that it cannot yet quantify. On the balance sheet, the company sits comfortably with $204.3 million of cash and marketable securities plus an untouched $300 million revolver, and it bought back $11.7 million of stock in the quarter.

How filings like this one have moved

In the 30 days to Oct 21, 2026, 29.2% of the 1544 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HCSG was trading at $21.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $16.27 to $25.75. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCSG - Latest Insights

HCSG
Oct 21, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $21.50
Real-time Price: $21.67 info
Change: +$0.170 (+0.79%) info
Market Cap: $1.476B info
HCSG
Oct 07, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.79
Real-time Price: $21.67 info
Change: +$0.880 (+4%) info
Market Cap: $1.476B info
HCSG
Oct 07, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $21.13
Real-time Price: $21.67 info
Change: +$0.540 (+3%) info
Market Cap: $1.476B info
HCSG
Jul 24, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.74
Real-time Price: $21.67 info
Change: -$1.07 (-5%) info
Market Cap: $1.476B info
HCSG
May 27, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.60
Real-time Price: $21.67 info
Change: +$1.07 (+5%) info
Market Cap: $1.476B info